The results of this study showed that the incidence rate of PRCa was higher in BPH patients having a CYP3A4*1B genotype compared to those homozygous for CYP3A4*1A, but it was not statistically significant. This evidence concerns the gene CYP3A4 and benign prostatic hyperplasia.